Kura Oncology is a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment. The company's pipeline includes ziftomenib, tipifarnib, and KO-2806, targeting specific signaling pathways and drivers of cancer to improve patient outcomes. Kura emphasizes personalized medicine approaches and innovative research in solid tumors and blood cancers.
Kura Oncology is seeking a Vice President of Global Program Leadership to oversee the development and commercialization of ziftomenib, a menin inhibitor targeting cancer treatment. This role requires a seasoned executive with a collaborative leadership style, dedicated to building a diverse, talent-driven organization focused on innovation and patient-centricity. The Vice President will drive cross-functional teams, develop strategic objectives, and represent the program to internal and external stakeholders.
Kura Oncology is a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment. The company's pipeline includes ziftomenib, tipifarnib, and KO-2806, targeting specific signaling pathways and drivers of cancer to improve patient outcomes. Kura emphasizes personalized medicine approaches and innovative research in solid tumors and blood cancers.
Natera